Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

Lung T1 mapping magnetic resonance imaging in the assessment of pulmonary disease in children with cystic fibrosis: a pilot study.

Neemuchwala F, Ghadimi Mahani M, Pang Y, Lee E, Johnson TD, Galbán CJ, Fortuna AB, Sanchez-Jacob R, Flask CA, Nasr SZ.

Pediatr Radiol. 2020 Mar 11. doi: 10.1007/s00247-020-04638-9. [Epub ahead of print]

PMID:
32162080
2.

CF: There's an app for that!

Nasr SZ, Lechtzin N.

J Cyst Fibros. 2020 Feb 20. pii: S1569-1993(20)30051-5. doi: 10.1016/j.jcf.2020.02.005. [Epub ahead of print] No abstract available.

PMID:
32089516
3.

N-acetylcysteine for Management of Distal Intestinal Obstruction Syndrome.

Schauble AL, Bisaccia EK, Lee G, Nasr SZ.

J Pediatr Pharmacol Ther. 2019 Sep-Oct;24(5):390-397. doi: 10.5863/1551-6776-24.5.390. Review.

4.

The future of cystic fibrosis care: a global perspective.

Bell SC, Mall MA, Gutierrez H, Macek M, Madge S, Davies JC, Burgel PR, Tullis E, Castaños C, Castellani C, Byrnes CA, Cathcart F, Chotirmall SH, Cosgriff R, Eichler I, Fajac I, Goss CH, Drevinek P, Farrell PM, Gravelle AM, Havermans T, Mayer-Hamblett N, Kashirskaya N, Kerem E, Mathew JL, McKone EF, Naehrlich L, Nasr SZ, Oates GR, O'Neill C, Pypops U, Raraigh KS, Rowe SM, Southern KW, Sivam S, Stephenson AL, Zampoli M, Ratjen F.

Lancet Respir Med. 2020 Jan;8(1):65-124. doi: 10.1016/S2213-2600(19)30337-6. Epub 2019 Sep 27. Review. Erratum in: Lancet Respir Med. 2019 Dec;7(12):e40.

PMID:
31570318
5.

Progressive Scoliosis in a Child with Cystic Fibrosis.

Castner LM, Nasr SZ, Arteta M.

Case Rep Pediatr. 2019 Apr 10;2019:1471879. doi: 10.1155/2019/1471879. eCollection 2019.

6.

Sleep disturbances and their impact in pediatric cystic fibrosis.

Shakkottai A, O'Brien LM, Nasr SZ, Chervin RD.

Sleep Med Rev. 2018 Dec;42:100-110. doi: 10.1016/j.smrv.2018.07.002. Epub 2018 Jul 6. Review.

7.

Newborn Screening Saves Lives but Cannot Replace the Need for Clinical Vigilance.

Neemuchwala F, Taki M, Secord E, Nasr SZ.

Case Rep Pediatr. 2018 Jul 2;2018:7217326. doi: 10.1155/2018/7217326. eCollection 2018.

8.

Impact of home spirometry on medication adherence among adolescents with cystic fibrosis.

Shakkottai A, Kaciroti N, Kasmikha L, Nasr SZ.

Pediatr Pulmonol. 2018 Apr;53(4):431-436. doi: 10.1002/ppul.23950. Epub 2018 Feb 19.

9.

Prevalence of Pelvic Incontinence in Patients With Cystic Fibrosis.

Neemuchwala F, Ahmed F, Nasr SZ.

Glob Pediatr Health. 2017 Nov 28;4:2333794X17743424. doi: 10.1177/2333794X17743424. eCollection 2017.

10.

The impact of conventional and nonconventional inhalants on children and adolescents.

Nasr SZ, Nasrallah AI, Abdulghani M, Sweet SC.

Pediatr Pulmonol. 2018 Apr;53(4):391-399. doi: 10.1002/ppul.23836. Epub 2017 Oct 30. Review.

11.

Overcoming barriers to a successful transition from pediatric to adult care.

Goralski JL, Nasr SZ, Uluer A.

Pediatr Pulmonol. 2017 Nov;52(S48):S52-S60. doi: 10.1002/ppul.23778. Epub 2017 Sep 26. Review.

12.

Prevalence of hearing and vestibular loss in cystic fibrosis patients exposed to aminoglycosides.

Handelsman JA, Nasr SZ, Pitts C, King WM.

Pediatr Pulmonol. 2017 Sep;52(9):1157-1162. doi: 10.1002/ppul.23763. Epub 2017 Jul 24.

13.

The Use of Home Spirometry in Pediatric Cystic Fibrosis Patients: Results of a Feasibility Study.

Shakkottai A, Nasr SZ.

Glob Pediatr Health. 2017 Feb 2;4:2333794X17690315. doi: 10.1177/2333794X17690315. eCollection 2017.

14.

Extended-Interval Aminoglycoside Use in Cystic Fibrosis Exacerbation in Children and Young Adults: A Prospective Quality Improvement Project.

Safi KH, Damiani JM, Sturza J, Nasr SZ.

Glob Pediatr Health. 2016 Mar 4;3:2333794X16635464. doi: 10.1177/2333794X16635464. eCollection 2016.

15.

Refining the continuum of CFTR-associated disorders in the era of newborn screening.

Levy H, Nugent M, Schneck K, Stachiw-Hietpas D, Laxova A, Lakser O, Rock M, Dahmer MK, Biller J, Nasr SZ, Baker M, McColley SA, Simpson P, Farrell PM.

Clin Genet. 2016 May;89(5):539-49. doi: 10.1111/cge.12711. Epub 2016 Jan 20.

16.

A five-year retrospective analysis of adherence in cystic fibrosis.

Shakkottai A, Kidwell KM, Townsend M, Nasr SZ.

Pediatr Pulmonol. 2015 Dec;50(12):1224-9. doi: 10.1002/ppul.23307. Epub 2015 Sep 7.

PMID:
26346919
17.

Electronic Cigarette Use in Middle and High School Students Triples from 2013 to 2014.

Nasr SZ, Sweet SC; ATS Health Policy Committee.

Am J Respir Crit Care Med. 2015 Aug 1;192(3):276-8. doi: 10.1164/rccm.201505-0898ED. No abstract available.

PMID:
26230233
18.

Behavioral and nutritional treatment for preschool-aged children with cystic fibrosis: a randomized clinical trial.

Powers SW, Stark LJ, Chamberlin LA, Filigno SS, Sullivan SM, Lemanek KL, Butcher JL, Driscoll KA, Daines CL, Brody AS, Schindler T, Konstan MW, McCoy KS, Nasr SZ, Castile RG, Acton JD, Wooldridge JL, Ksenich RA, Szczesniak RD, Rausch JR, Stallings VA, Zemel BS, Clancy JP.

JAMA Pediatr. 2015 May;169(5):e150636. doi: 10.1001/jamapediatrics.2015.0636. Epub 2015 May 4.

PMID:
25938655
19.

Effect of treatment of cystic fibrosis pulmonary exacerbations on systemic inflammation.

Sagel SD, Thompson V, Chmiel JF, Montgomery GS, Nasr SZ, Perkett E, Saavedra MT, Slovis B, Anthony MM, Emmett P, Heltshe SL.

Ann Am Thorac Soc. 2015 May;12(5):708-17. doi: 10.1513/AnnalsATS.201410-493OC.

20.

Improving nutritional status in a pediatric cystic fibrosis center.

Ramírez I, Filbrun A, Hasan A, Kidwell KM, Nasr SZ.

Pediatr Pulmonol. 2015 Jun;50(6):544-51. doi: 10.1002/ppul.23128. Epub 2014 Nov 11.

21.

Direct observation of respiratory treatments in cystic fibrosis: parent-child interactions relate to medical regimen adherence.

Butcher JL, Nasr SZ.

J Pediatr Psychol. 2015 Jan-Feb;40(1):8-17. doi: 10.1093/jpepsy/jsu074. Epub 2014 Sep 17.

PMID:
25236709
22.
23.

Hypervitaminosis A causing hypercalcemia in cystic fibrosis. Case report and focused review.

Safi KH, Filbrun AG, Nasr SZ.

Ann Am Thorac Soc. 2014 Oct;11(8):1244-7. doi: 10.1513/AnnalsATS.201404-170BC. Review.

PMID:
25188737
24.

Primary care providers' experiences notifying parents of cystic fibrosis newborn screening results.

Finan C, Nasr SZ, Rothwell E, Tarini BA.

Clin Pediatr (Phila). 2015 Jan;54(1):67-75. doi: 10.1177/0009922814545619. Epub 2014 Aug 6.

25.

Improving the Rate of Sufficient Sweat Collected in Infants Referred for Sweat Testing in Michigan.

Abdulhamid I, Kleyn M, Langbo C, Gregoire-Bottex M, Schuen J, Shanmugasundaram K, Nasr SZ.

Glob Pediatr Health. 2014 Oct 9;1:2333794X14553625. doi: 10.1177/2333794X14553625. eCollection 2014.

26.

Tobramycin inhalation powder in cystic fibrosis patients: response by age group.

Geller DE, Nasr SZ, Piggott S, He E, Angyalosi G, Higgins M.

Respir Care. 2014 Mar;59(3):388-98. doi: 10.4187/respcare.02264. Epub 2013 Aug 27.

27.

Adherence to dornase alfa treatment among commercially insured patients with cystic fibrosis.

Nasr SZ, Chou W, Villa KF, Chang E, Broder MS.

J Med Econ. 2013;16(6):801-8. doi: 10.3111/13696998.2013.787427. Epub 2013 Apr 4.

PMID:
23506540
28.

Providing support through life's final chapter for those who made it home.

Antoni C, Silverman MA, Nasr SZ, Mandi D, Golden AG.

Mil Med. 2012 Dec;177(12):1498-501.

PMID:
23397695
29.

Evaluation of genetic counseling among cystic fibrosis carriers, Michigan Newborn Screening.

Kleyn MJ, Langbo C, Abdulhamid I, Adamski CR, Allan C, Carmany EP, Gregoire-Bottex MM, Homnick D, Schuen J, Nasr SZ.

Pediatr Pulmonol. 2013 Feb;48(2):123-9. doi: 10.1002/ppul.22703. Epub 2012 Nov 20.

30.

Who counsels parents of newborns who are carriers of sickle cell anemia or cystic fibrosis?

Moseley KL, Nasr SZ, Schuette JL, Campbell AD.

J Genet Couns. 2013 Apr;22(2):218-25. doi: 10.1007/s10897-012-9537-3. Epub 2012 Aug 18.

31.

Evaluation of a cystic fibrosis transition program from pediatric to adult care.

Chaudhry SR, Keaton M, Nasr SZ.

Pediatr Pulmonol. 2013 Jul;48(7):658-65. doi: 10.1002/ppul.22647. Epub 2012 Aug 8.

32.

Inducing sputum in patients with cystic fibrosis could be helpful, but is time-consuming and expensive.

Nasr SZ.

J Pediatr. 2011 May;158(5):862. doi: 10.1016/j.jpeds.2011.03.015. No abstract available.

PMID:
21482251
33.

Efficacy and Safety of a New Formulation of Pancrelipase (Ultrase MT20) in the Treatment of Malabsorption in Exocrine Pancreatic Insufficiency in Cystic Fibrosis.

Konstan MW, Liou TG, Strausbaugh SD, Ahrens R, Kanga JF, Graff GR, Moffett K, Millard SL, Nasr SZ, Siméon E, Spénard J, Grondin J.

Gastroenterol Res Pract. 2010;2010:898193. doi: 10.1155/2010/898193. Epub 2010 Dec 8.

34.

Variation in immunoreactive trypsinogen concentrations among Michigan newborns and implications for cystic fibrosis newborn screening.

Korzeniewski SJ, Young WI, Hawkins HC, Cavanagh K, Nasr SZ, Langbo C, Teneyck KR, Grosse SD, Kleyn M, Grigorescu V.

Pediatr Pulmonol. 2011 Feb;46(2):125-30. doi: 10.1002/ppul.21330. Epub 2010 Sep 16.

35.

Identifying barriers to treatment adherence and related attitudinal patterns in adolescents with cystic fibrosis.

Dziuban EJ, Saab-Abazeed L, Chaudhry SR, Streetman DS, Nasr SZ.

Pediatr Pulmonol. 2010 May;45(5):450-8. doi: 10.1002/ppul.21195.

36.

The use of high resolution computerized tomography (HRCT) of the chest in evaluating the effect of tobramycin solution for inhalation in cystic fibrosis lung disease.

Nasr SZ, Sakmar E, Christodoulou E, Eckhardt BP, Streetman DS, Strouse PJ.

Pediatr Pulmonol. 2010 May;45(5):440-9. doi: 10.1002/ppul.21188.

37.

EUR-1008 pancreatic enzyme replacement is safe and effective in patients with cystic fibrosis and pancreatic insufficiency.

Wooldridge JL, Heubi JE, Amaro-Galvez R, Boas SR, Blake KV, Nasr SZ, Chatfield B, McColley SA, Woo MS, Hardy KA, Kravitz RM, Straforini C, Anelli M, Lee C.

J Cyst Fibros. 2009 Dec;8(6):405-17. doi: 10.1016/j.jcf.2009.07.006. Epub 2009 Aug 15.

38.

Appetite stimulants use in cystic fibrosis.

Nasr SZ, Drury D.

Pediatr Pulmonol. 2008 Mar;43(3):209-19. doi: 10.1002/ppul.20766. Review.

39.

Long-term use of nebulized human recombinant DNase1 in two siblings with primary ciliary dyskinesia.

El-Abiad NM, Clifton S, Nasr SZ.

Respir Med. 2007 Oct;101(10):2224-6. Epub 2007 Jun 29.

40.

An 8-week behavioral intervention can improve weight gain in children with cystic fibrosis.

Nasr SZ.

J Pediatr. 2006 May;148(5):700-1. No abstract available.

PMID:
17243302
41.
42.

Inpatient health care use among adult survivors of chronic childhood illnesses in the United States.

Okumura MJ, Campbell AD, Nasr SZ, Davis MM.

Arch Pediatr Adolesc Med. 2006 Oct;160(10):1054-60.

PMID:
17018465
43.

Cystic fibrosis detection in high-risk Egyptian children and CFTR mutation analysis.

Naguib ML, Schrijver I, Gardner P, Pique LM, Doss SS, Abu Zekry MA, Aziz M, Nasr SZ.

J Cyst Fibros. 2007 Apr;6(2):111-6. Epub 2006 Jul 11.

44.

Adherence to treatment in children and adolescent patients with cystic fibrosis.

Zindani GN, Streetman DD, Streetman DS, Nasr SZ.

J Adolesc Health. 2006 Jan;38(1):13-7.

PMID:
16387243
45.

Randomized, double-blind, placebo-controlled, dose-escalating study of aerosolized interferon gamma-1b in patients with mild to moderate cystic fibrosis lung disease.

Moss RB, Mayer-Hamblett N, Wagener J, Daines C, Hale K, Ahrens R, Gibson RL, Anderson P, Retsch-Bogart G, Nasr SZ, Noth I, Waltz D, Zeitlin P, Ramsey B, Starko K.

Pediatr Pulmonol. 2005 Mar;39(3):209-18.

PMID:
15573395
46.

Use of laryngeal mask airway in flexible bronchoscopy in infants and children.

Naguib ML, Streetman DS, Clifton S, Nasr SZ.

Pediatr Pulmonol. 2005 Jan;39(1):56-63.

PMID:
15558607
47.

Clinical redesign using all patient refined diagnosis related groups.

Sedman AB, Bahl V, Bunting E, Bandy K, Jones S, Nasr SZ, Schulz K, Campbell DA.

Pediatrics. 2004 Oct;114(4):965-9.

PMID:
15466092
48.

Treatment with tobramycin solution for inhalation reduces hospitalizations in young CF subjects with mild lung disease.

Murphy TD, Anbar RD, Lester LA, Nasr SZ, Nickerson B, VanDevanter DR, Colin AA.

Pediatr Pulmonol. 2004 Oct;38(4):314-20.

PMID:
15334509
49.

Hypersensitivity to inhaled TOBI following reaction to gentamicin.

Spigarelli MG, Hurwitz ME, Nasr SZ.

Pediatr Pulmonol. 2002 Apr;33(4):311-4.

50.

Religious/spiritual coping in childhood cystic fibrosis: a qualitative study.

Pendleton SM, Cavalli KS, Pargament KI, Nasr SZ.

Pediatrics. 2002 Jan;109(1):E8.

PMID:
11773576

Supplemental Content

Support Center